Adamant Biomedical Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q4	$3.25M	Sell	36,000 -14,000	-28%	-$1.27M	0.78%	48
2014 Q3	$3.61M	Buy	+50,000	New	+$3.61M	0.9%	42